These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29356001)

  • 1. Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y
    Lemesle G; Laine M; Pankert M; Puymirat E; Cuisset T; Boueri Z; Maillard L; Armero S; Cayla G; Bali L; Motreff P; Peyre JP; Paganelli F; Kerbaul F; Roch A; Michelet P; Baumstarck K; Bonello L
    Clin Cardiol; 2018 Jan; 41(1):5-12. PubMed ID: 29356001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment: The EARLY Randomized Trial.
    Lemesle G; Laine M; Pankert M; Boueri Z; Motreff P; Paganelli F; Baumstarck K; Roch A; Kerbaul F; Puymirat E; Bonello L
    JACC Cardiovasc Interv; 2020 Apr; 13(8):907-917. PubMed ID: 32327087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome.
    Damman P; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ;
    J Am Coll Cardiol; 2010 Mar; 55(9):858-64. PubMed ID: 20045278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early invasive strategy in high-risk acute coronary syndrome without ST-segment elevation. The Sisca randomized trial.
    Reuter PG; Rouchy C; Cattan S; Benamer H; Jullien T; Beruben A; Montely JM; Assez N; Raphael V; Hennequin B; Boccara A; Javaud N; Soulat L; Adnet F; Lapostolle F
    Int J Cardiol; 2015 Mar; 182():414-8. PubMed ID: 25596468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial.
    Pollack CV; Davoudi F; Diercks DB; Becker RC; James SK; Lim ST; Schulte PJ; Spinar J; Steg PG; Storey RF; Himmelmann A; Wallentin L; Cannon CP;
    Clin Cardiol; 2017 Jun; 40(6):390-398. PubMed ID: 28598510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Rationale of the APELOT Trial: A Randomized, Open-Label, Multicenter, Phase IV Study to Evaluate the Antiplatelet Effect of Different Loading Dose of Ticagrelor in Patients With Non-ST Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Liu HL; Wei YJ; Jin ZG; Zhang J; Ding P; Yang SL; Luo JP; Ma DX; Liu Y; Han W
    Medicine (Baltimore); 2016 May; 95(22):e3756. PubMed ID: 27258504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial.
    Hoedemaker NPG; Damman P; Woudstra P; Hirsch A; Windhausen F; Tijssen JGP; de Winter RJ;
    J Am Coll Cardiol; 2017 Apr; 69(15):1883-1893. PubMed ID: 28408018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.
    Montalescot G; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; ten Berg JM; Miller DL; Costigan TM; Goedicke J; Silvain J; Angioli P; Legutko J; Niethammer M; Motovska Z; Jakubowski JA; Cayla G; Visconti LO; Vicaut E; Widimsky P;
    N Engl J Med; 2013 Sep; 369(11):999-1010. PubMed ID: 23991622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis.
    Bonello L; Laine M; Puymirat E; Lemesle G; Thuny F; Paganelli F; Michelet P; Roch A; Kerbaul F; Boyer L
    JACC Cardiovasc Interv; 2016 Nov; 9(22):2267-2276. PubMed ID: 27884352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.
    Bonello L; Laine M; Camoin-Jau L; Noirot F; Guieu R; Dignat-George F; Paganelli F; Frere C
    Thromb Haemost; 2015 Oct; 114(4):702-7. PubMed ID: 26311415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Pretreatment With Oral P2Y12 Inhibitors and Cardiovascular and Bleeding Outcomes in Patients With Non-ST Elevation Acute Coronary Syndromes: A Systematic Review and Meta-analysis.
    Dawson LP; Chen D; Dagan M; Bloom J; Taylor A; Duffy SJ; Shaw J; Lefkovits J; Stub D
    JAMA Netw Open; 2021 Nov; 4(11):e2134322. PubMed ID: 34797371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With Outcomes.
    Dworeck C; Redfors B; Angerås O; Haraldsson I; Odenstedt J; Ioanes D; Petursson P; Völz S; Persson J; Koul S; Venetsanos D; Ulvenstam A; Hofmann R; Jensen J; Albertsson P; Råmunddal T; Jeppsson A; Erlinge D; Omerovic E
    JAMA Netw Open; 2020 Oct; 3(10):e2018735. PubMed ID: 33001202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial.
    Badings EA; The SH; Dambrink JH; van Wijngaarden J; Tjeerdsma G; Rasoul S; Timmer JR; van der Wielen ML; Lok DJ; van 't Hof AW
    EuroIntervention; 2013 May; 9(1):54-61. PubMed ID: 23685295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization.
    Elbarasi E; Goodman SG; Yan RT; Welsh RC; Kornder J; Wong GC; Déry JP; Anderson F; Gore JM; Fox KA; Yan AT; ;
    Am Heart J; 2010 Jan; 159(1):40-6. PubMed ID: 20102865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of invasive strategy in NSTE-ACS patients and effect on clinical outcomes: A systematic review and meta-analysis of randomized controlled trials.
    Milasinovic D; Milosevic A; Marinkovic J; Vukcevic V; Ristic A; Asanin M; Stankovic G
    Atherosclerosis; 2015 Jul; 241(1):48-54. PubMed ID: 25966439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
    Steg PG; Mehta S; Jolly S; Xavier D; Rupprecht HJ; Lopez-Sendon JL; Chrolavicius S; Rao SV; Granger CB; Pogue J; Laing S; Yusuf S
    Am Heart J; 2010 Dec; 160(6):1029-34, 1034.e1. PubMed ID: 21146654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis.
    O'Donoghue M; Boden WE; Braunwald E; Cannon CP; Clayton TC; de Winter RJ; Fox KA; Lagerqvist B; McCullough PA; Murphy SA; Spacek R; Swahn E; Wallentin L; Windhausen F; Sabatine MS
    JAMA; 2008 Jul; 300(1):71-80. PubMed ID: 18594042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.
    Barbarawi M; Kheiri B; Zayed Y; Barbarawi O; Chahine A; Haykal T; Kanugula AK; Bachuwa G; Alkotob ML; Bhatt DL
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):185-193. PubMed ID: 31111670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial.
    Kim JS; Han DC; Jeong YH; Park DW; Sohn CB; Hwang KW; Lee SH; Choi JH; Chon MK; Lee SY; Hwang J; Kim IS; Lee SM; Han J; Noh M; Kim CH; Chun KJ; Park YH; Kim JH
    Thromb Haemost; 2016 Jan; 115(1):213-21. PubMed ID: 26581884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.